Koru Medical Systems, INC Form 4 insider transactions

NASDAQ
Kenneth E. Miller, Chief Commercial Officer of KORU Medical Systems, reports the acquisition of restricted stock units and stock options in a recent Form 4 filing.
NASDAQ
Chief Financial Officer of KORU Medical Systems, Thomas Edward Adams, reports the acquisition of restricted stock units and stock options.
NASDAQ
Horton Capital Partners Fund, L.P. distributed 721,781 shares of KORU Medical Systems, Inc. common stock to its limited partners on July 24, 2024.
NASDAQ
Joseph M. Manko, Jr., a director of KORU Medical Systems, received 5,545 shares of common stock for his service as a director for the quarter ended June 30, 2024.
NASDAQ
Director Edward Wholihan reports acquisition of 5,545 shares of Koru Medical Systems at $2.71 per share and disposal of 18,322 shares.
NASDAQ
Director Shahriar Matin acquired 5,545 shares of Koru Medical Systems, Inc. at a price of $2.71 on July 11, 2024, increasing his total holdings to 68,154 shares.
NASDAQ
Director Donna French acquired 5,545 shares of Koru Medical Systems at $2.71 per share on July 11, 2024.
NASDAQ
R. John Fletcher, a director at Koru Medical Systems, reported acquiring 8,371 shares of common stock at $2.71 per share on July 11, 2024.
NASDAQ
Director Robert Cascella reported acquiring 5,545 shares of Koru Medical Systems at $2.71 per share on July 11, 2024, increasing his total holdings to 65,524 shares.
NASDAQ
Joseph M. Manko Jr., a director of KORU Medical Systems, received 6,329 shares of common stock on March 31, 2024, as compensation for his board service.
NASDAQ
Director Edward Wholihan reported acquiring 6,329 shares of KORU Medical Systems at $2.37 per share on March 31, 2024.
NASDAQ
Director Shahriar Matin acquired 6,329 shares of KORU Medical Systems at $2.37 per share on March 31, 2024.
NASDAQ
Director Donna French acquired 6,329 shares of KORU Medical Systems at $2.37 per share on March 31, 2024.
NASDAQ
John Fletcher, a director at KORU Medical Systems, reported acquiring 9,493 shares of common stock at $2.37 per share on March 31, 2024.
NASDAQ
Director Robert Cascella acquired 6,329 shares of KORU Medical Systems at $2.37 per share on March 31, 2024.
NASDAQ
Linda Tharby, CEO of KORU Medical Systems, reports acquisition of shares as part of her bonus and disposition of shares for tax obligations.